Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

PTCT

PTC Therapeutics Inc

Apr 18 • 02:53PM ET

24.88

Dollar change -0.28
Percentage change -1.11	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VB IWM FBT VXF VBK IBB IWO SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-8.37	Insider Own	3.79%	Shs Outstand	75.71M	Perf Week	-9.20%
Market Cap	1.91B	Forward P/E	-	EPS next Y	-4.92	Insider Trans	-1.33%	Shs Float	73.71M	Perf Month	-18.24%
Income	-626.60M	PEG	-	EPS next Q	-1.28	Inst Own	110.35%	Short Float	13.92%	Perf Quarter	-8.96%
Sales	937.82M	P/S	2.03	EPS this Y	26.53%	Inst Trans	1.90%	Short Ratio	11.21	Perf Half Y	20.72%
Book/sh	-10.81	P/B	-	EPS next Y	20.02%	ROA	-34.73%	Short Interest	10.26M	Perf Year	-53.02%
Cash/sh	11.44	P/C	2.17	EPS next 5Y	-9.51%	ROE	-	52W Range	17.53 - 59.84	Perf YTD	-9.72%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-24.94%	ROI	-	52W High	-58.42%	Beta	0.70
Dividend TTM	-	Quick Ratio	1.97	Sales past 5Y	29.08%	Gross Margin	69.28%	52W Low	41.93%	ATR (14)	1.34
Dividend Ex-Date	-	Current Ratio	2.02	EPS Y/Y TTM	-7.52%	Oper. Margin	-37.26%	RSI (14)	34.28	Volatility	4.93% 5.00%
Employees	995	Debt/Eq	-	Sales Y/Y TTM	34.20%	Profit Margin	-66.81%	Recom	2.93	Target Price	29.17
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	12.28%	Payout	-	Rel Volume	0.45	Prev Close	25.16
Sales Surprise	-2.51%	EPS Surprise	-1390.59%	Sales Q/Q	83.41%	Earnings	Apr 25 AMC	Avg Volume	914.92K	Price	24.88
SMA20	-10.55%	SMA50	-11.24%	SMA200	-14.86%	Trades		Volume	343,270	Change	-1.11%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-19-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$28
Dec-08-23	Initiated	Wells Fargo	Overweight	$37
Oct-30-23	Upgrade	Oppenheimer	Perform → Outperform	$165
Oct-27-23	Downgrade	Citigroup	Neutral → Sell	$29 → $17
Oct-06-23	Downgrade	Truist	Buy → Hold	$45 → $25
Sep-18-23	Downgrade	Citigroup	Buy → Neutral	$55 → $28
Sep-15-23	Downgrade	Raymond James	Outperform → Underperform
Mar-17-23	Initiated	SVB Securities	Market Perform	$48
Dec-14-22	Initiated	Goldman	Sell	$35
Sep-12-22	Initiated	Jefferies	Buy	$62
Sep-09-22	Initiated	Morgan Stanley	Equal-Weight	$54
Sep-01-22	Initiated	Citigroup	Buy	$70
Apr-04-22	Resumed	Cantor Fitzgerald	Overweight	$64 → $63
Oct-18-21	Downgrade	BofA Securities	Neutral → Underperform	$38
Apr-26-21	Resumed	Credit Suisse	Neutral	$54
Mar-29-21	Upgrade	RBC Capital Mkts	Underperform → Sector Perform	$47
Feb-12-21	Downgrade	BofA Securities	Buy → Neutral
Jan-05-21	Upgrade	Citigroup	Neutral → Buy	$67 → $85
Nov-30-20	Downgrade	RBC Capital Mkts	Sector Perform → Underperform	$45
Oct-30-20	Downgrade	Citigroup	Buy → Neutral

Show Previous Ratings

Today 10:01AM	PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Apr-11-24 08:00AM	PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results (PR Newswire)
Mar-28-24 08:30AM	PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA (PR Newswire)
Mar-25-24 10:00AM	A Comprehensive Look at Sarepta's Growth and Innovation (GuruFocus.com)
Mar-20-24 02:00PM	PTC Therapeutics (PTCT) Up on Positive Regulatory Updates (Zacks)
07:30AM	Loading…
Mar-19-24 07:30AM	PTC Therapeutics Provides Key Regulatory Updates (PR Newswire)
Mar-02-24 08:56AM	PTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 06:51AM	Q4 2023 PTC Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) +13.34%
Feb-29-24 06:00PM	Here's What Key Metrics Tell Us About PTC Therapeutics (PTCT) Q4 Earnings (Zacks)
05:20PM	PTC Therapeutics (PTCT) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:33PM	PTC Therapeutics Inc (PTCT) Reports Robust Revenue Growth and Advances in Pipeline (GuruFocus.com)
04:30PM	PTC Therapeutics: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results (PR Newswire)
Feb-27-24 05:20PM	PTC Therapeutics to Participate at Upcoming Investor Conferences (PR Newswire)
Feb-26-24 09:16AM	Wall Street's Insights Into Key Metrics Ahead of PTC Therapeutics (PTCT) Q4 Earnings (Zacks)
04:30PM	Loading…
Feb-22-24 04:30PM	PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Feb-15-24 08:00AM	PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results (PR Newswire)
Feb-13-24 10:00AM	PTC Therapeutics (PTCT) to Report Q4 Results: Wall Street Expects Earnings Growth (Zacks) -6.83%
Feb-11-24 01:45AM	1 of Sarepta Therapeutics' Competitors Just Got Hammered. Will It Help the Stock? (Motley Fool)
Jan-26-24 04:06PM	PTC Therapeutics Recovers From An Ugly Fall After European Officials Reject DMD Drug (Investor's Business Daily)
11:45AM	PTC Therapeutics Recovers, Mostly, After European Officials Reject DMD Drug (Investor's Business Daily)
10:18AM	PTC Therapeutics Flashes A Bearish Sign After European Officials Reject DMD Drug (Investor's Business Daily)
Jan-25-24 04:51PM	UPDATE 1-Europe to withdraw PTC Therapeutics' rare muscle disorder drug (Reuters)
04:20PM	PTC Therapeutics' muscle disorder drug fails to secure EU regulator backing (Reuters)
04:05PM	CHMP Issues Negative Opinion for Renewal of Conditional Marketing Authorization for Translarna (ataluren) Following Re-examination Procedure (PR Newswire)
Jan-24-24 07:02PM	PTC Therapeutics Inc Director Allan Jacobson Sells 10,000 Shares (GuruFocus.com)
Jan-12-24 01:02AM	PTC Therapeutics Inc Chief Business Officer Eric Pauwels Sells 3,634 Shares (GuruFocus.com) -5.01%
Jan-08-24 09:26AM	PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire) +7.49%
Jan-03-24 08:00AM	PTC Therapeutics to Participate at 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-20-23 09:41AM	Analysts on Wall Street Lower Ratings for These 5 Stocks (Insider Monkey)
05:01PM	Loading…
Dec-15-23 05:01PM	Insider Buying: CFO Pierre Gravier Acquires 7,700 Shares of PTC Therapeutics Inc (PTCT) (GuruFocus.com)
Dec-14-23 04:30PM	PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Dec-05-23 04:15PM	PTC Therapeutics Provides Updates on Translarna Regulatory Activities (PR Newswire)
Nov-14-23 03:58PM	FMR LLC Trims Stake in PTC Therapeutics Inc (GuruFocus.com) +9.71%
Nov-03-23 04:30PM	PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire) +8.08%
Oct-30-23 09:03AM	PTC Therapeutics, Inc. (NASDAQ:PTCT) Q3 2023 Earnings Call Transcript (Insider Monkey)
Oct-27-23 11:22AM	Q3 2023 PTC Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) -22.71%
10:01AM	Roblox upgraded, Bristol Myers downgraded: Wall Street's top analyst calls (The Fly)
08:33AM	Why Is PTC Therapeutics (PTCT) Stock Down 23% Today? (InvestorPlace)
07:15AM	The Zacks Analyst Blog Highlights Bristol Myers, PTC Therapeutics, Beam Therapeutics and BioMarin Pharmaceutical (Zacks)
02:38AM	Southwest Airlines slashed at TD Cowen following Q3 miss: 4 big analyst cuts (Investing.com)
Oct-26-23 07:30PM	PTC Therapeutics (PTCT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:10PM	PTC Therapeutics Inc (PTCT) Reports Q3 2023 Earnings: Revenue of $197 Million (GuruFocus.com)
05:30PM	PTC Therapeutics (PTCT) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:25PM	PTC Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	PTC Therapeutics Provides Corporate Update and Reports Third Quarter Financial Results (PR Newswire)
Oct-24-23 10:00AM	Neurocrine Biosciences (NBIX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-19-23 07:02PM	Why PTC Therapeutics Soared 15% Higher Today (Motley Fool) +14.98%
10:01AM	PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
08:00AM	PTC Therapeutics Announces Evrysdi Royalty Agreement with Royalty Pharma for Up To $1.5 Billion (PR Newswire)
Oct-16-23 04:30PM	PTC Therapeutics to Host Conference Call to DiscussThird Quarter 2023 Financial Results (PR Newswire)
Oct-11-23 08:07AM	PTC Therapeutics (PTCT) Moves 5.3% Higher: Will This Strength Last? (Zacks)
Oct-06-23 09:42AM	e.l.f. Beauty upgraded, AutoZone downgraded: Wall Street's top analyst calls (The Fly)
Sep-29-23 11:18AM	PTC Therapeutics (PTCT) to Cut 25% Jobs by January 2024 (Zacks)
Sep-28-23 05:15PM	UPDATE 2-PTC Therapeutics announces job cuts to lower annual operating expenses (Reuters)
04:42PM	PTC Therapeutics announces job cuts (Reuters)
04:30PM	PTC Announces Further Strategic Prioritization and Associated Reduction in Workforce (PR Newswire)
Sep-25-23 03:18AM	PTC Therapeutics (PTCT) Lost 16% in Q2 (Insider Monkey) -5.69%
Sep-20-23 04:00AM	PTC Therapeutics (PTCT) Surges 5.8%: Is This an Indication of Further Gains? (Zacks)
Sep-19-23 06:46AM	Analysts on Wall Street Lower Ratings for These 10 Stocks (Insider Monkey) +5.77%
Sep-15-23 04:04PM	Biotech Crashes 30% After European Regulators Yank Approval For Muscle Disease Drug (Investor's Business Daily) -29.77%
09:28AM	PTC Therapeutics Crashes 29% After European Regulators Reject Its Muscular Dystrophy Drug (Investor's Business Daily)
06:00AM	CHMP Delivers Opinion on Translarna for Conversion to Full Authorization (PR Newswire)
Sep-12-23 08:00AM	Sensorium Therapeutics Appoints Veteran Life Sciences Executive Mr. David Southwell to its Board of Directors (GlobeNewswire)
Sep-07-23 07:33PM	Is PTC Therapeutics (PTCT) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap (GuruFocus.com)
08:00AM	PTC Therapeutics' 2023 STRIVE Awards Program Funds Initiatives Supporting the Duchenne Patient Community (PR Newswire)
08:00AM	Australian Patient Advocacy Organization Named a Recipient of PTC Therapeutics' 2023 STRIVE Award for Duchenne Muscular Dystrophy (PR Newswire)
Aug-30-23 08:00AM	PTC Therapeutics to Participate at Upcoming Investor Conferences (PR Newswire)
Aug-28-23 08:00AM	PTC Therapeutics to Present Recent Data for Sepiapterin at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium (PR Newswire)
Aug-25-23 01:38PM	Untapped Potential: 3 Stocks Tackling the Toughest Rare Diseases (InvestorPlace)
Aug-04-23 01:24PM	PTC Therapeutics, Inc. (NASDAQ:PTCT) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-03-23 09:30PM	PTC Therapeutics (PTCT) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:25PM	PTC Therapeutics (PTCT) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:14PM	PTC Therapeutics: Q2 Earnings Snapshot (AP Finance)
04:01PM	PTC Therapeutics Provides Corporate Update and Reports Second Quarter Financial Results (PR Newswire)
Jul-21-23 09:30AM	CHMP Recommends Evrysdi® for Babies Under Two Months Old with Spinal Muscular Atrophy (PR Newswire)
Jul-20-23 08:00AM	PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2023 Financial Results (PR Newswire)
Jul-19-23 04:30PM	PTC Therapeutics Co-Founder Allan Jacobson, Ph.D., Awarded 2023 Gruber Genetics Prize (PR Newswire)
Jul-18-23 04:30PM	PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Jul-17-23 04:30PM	PTC Therapeutics Appoints Experienced Healthcare Finance Strategist Pierre Gravier as Chief Financial Officer (PR Newswire)
Jul-11-23 12:00PM	PTC Therapeutics Announces Virtual Presentation on Phenylketonuria (PKU) and Sepiapterin (PR Newswire)
Jun-30-23 10:18AM	PTC Therapeutics' Seizure Study Fails To Meet Primary Goal, Analyst Says Minimal Impact On Investment Thesis (Benzinga)
Jun-29-23 04:30PM	PTC Therapeutics Announces Results from MIT-E Clinical Trial of Vatiquinone for the Treatment of Mitochondrial Disease Associated Seizures (PR Newswire)
09:18AM	Reata's (RETA) Skyclarys PAS Gets FDA Nod, Stock Rises 7% (Zacks)
Jun-28-23 07:41AM	PTC Therapeutics' (NASDAQ:PTCT) investors will be pleased with their 21% return over the last five years (Simply Wall St.)
Jun-21-23 04:24PM	PTC Therapeutics Says Interim Data For Huntington's Disease Candidate Shows Promise In Mid-Stage Study (Benzinga)
07:31AM	UPDATE 1-PTC Therapeutics Huntington's disease drug shows promise in mid-stage trial (Reuters)
07:12AM	PTC Therapeutics Huntington's disease drug shows promise in mid-stage trial (Reuters)
07:00AM	PTC Therapeutics Shares Positive Interim Data from PIVOT-HD Clinical Trial in Huntington's Disease Patients (PR Newswire)
Jun-15-23 04:30PM	PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Jun-02-23 08:00AM	PTC Therapeutics to Participate at Upcoming Investor Conferences (PR Newswire)
May-31-23 06:05AM	PTC Therapeutics, Inc. (NASDAQ:PTCT) Might Not Be As Mispriced As It Looks After Plunging 25% (Simply Wall St.)
May-25-23 10:32AM	Biotech Stock Roundup: IRWD Announces Buyout, ICPT, SRPT & PTCT Fall on Updates (Zacks) -7.43%
May-24-23 04:06PM	PTC Therapeutics' Barrage Of Bad News Is Good News For Rival Reata Pharmaceuticals Here's Why (Investor's Business Daily) -19.62%
12:48PM	PTC Therapeutics' (PTCT) Rare Disease Drug Fails in Study (Zacks)
12:33PM	PTC Therapeutics Stock Tumbles: Company Stops Preclinical Gene Therapy Programs After Failed Friedreich's Ataxia Study (Benzinga)
May-23-23 05:36PM	PTC Therapeutics Takes Investors On A Ride With A Failed Study, Scrapped Programs, Ousted CFO (Investor's Business Daily)
04:07PM	PTC Therapeutics Announces Topline Results from Vatiquinone MOVE-FA Registration-Directed Trial (PR Newswire)
04:05PM	PTC Therapeutics Announces Strategic Pipeline Prioritization (PR Newswire)
May-18-23 12:59PM	PTC Therapeutics' (PTCT) PKU Drug Meets Study Goal, Up 7.6% (Zacks)

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Golden Lee Scott	EVP & CHIEF MEDICAL OFFICER	Apr 02 '24	Sale	28.37	526	14,923	59,988	Apr 04 05:16 PM
Boulding Mark Elliott	EXEC. VP AND CLO	Jan 30 '24	Sale	27.25	794	21,637	71,189	Feb 01 04:17 PM
Almstead Neil Gregory	CHIEF TECHNICAL OPS OFFICER	Jan 30 '24	Sale	27.25	618	16,841	61,202	Feb 01 04:18 PM
Pauwels Eric	CHIEF BUSINESS OFFICER	Jan 30 '24	Sale	27.25	366	9,974	44,181	Feb 01 04:16 PM
Utter Christine Marie	SVP, CHIEF ACCOUNTING OFFICER	Jan 30 '24	Sale	27.25	318	8,666	35,528	Feb 01 04:15 PM
Almstead Neil Gregory	CHIEF TECHNICAL OPS OFFICER	Jan 30 '24	Sale	27.25	28	763	3,706	Feb 01 04:18 PM
Jacobson Allan Steven	Director	Jan 22 '24	Option Exercise	27.05	10,000	270,500	22,348	Jan 24 04:30 PM
Jacobson Allan Steven	Director	Jan 22 '24	Sale	27.38	10,000	273,804	12,348	Jan 24 04:30 PM
Klein Matthew B.	CHIEF EXECUTIVE OFFICER	Jan 09 '24	Sale	29.01	5,443	157,928	160,475	Jan 10 04:08 PM
Pauwels Eric	CHIEF BUSINESS OFFICER	Jan 09 '24	Sale	29.01	2,065	59,916	44,547	Jan 10 04:09 PM
Boulding Mark Elliott	EXEC. VP AND CLO	Jan 09 '24	Sale	29.01	1,938	56,231	71,983	Jan 10 04:04 PM
Utter Christine Marie	SVP, FINANCE & CAO	Jan 09 '24	Sale	29.01	1,653	47,961	35,846	Jan 10 04:11 PM
Almstead Neil Gregory	CHIEF TECHNICAL OPS OFFICER	Jan 09 '24	Sale	29.01	1,521	44,132	61,820	Jan 10 04:03 PM
Golden Lee Scott	CHIEF MEDICAL OFFICER	Jan 09 '24	Sale	29.01	1,225	35,543	37,914	Jan 10 04:06 PM
Almstead Neil Gregory	CHIEF TECHNICAL OPS OFFICER	Jan 09 '24	Sale	29.01	100	2,901	3,734	Jan 10 04:03 PM
Klein Matthew B.	CHIEF EXECUTIVE OFFICER	Jan 08 '24	Sale	28.64	2,237	64,068	165,918	Jan 10 04:08 PM
Pauwels Eric	CHIEF BUSINESS OFFICER	Jan 08 '24	Sale	28.64	1,569	44,937	46,612	Jan 10 04:09 PM
Boulding Mark Elliott	EXEC. VP AND CLO	Jan 08 '24	Sale	28.64	1,457	41,729	73,921	Jan 10 04:04 PM
SCHMERTZLER MICHAEL	Director	Jan 08 '24	Sale	27.81	1,500	41,715	115,266	Jan 10 04:10 PM
Almstead Neil Gregory	CHIEF TECHNICAL OPS OFFICER	Jan 08 '24	Sale	28.64	1,236	35,399	63,341	Jan 10 04:03 PM
Utter Christine Marie	SVP, FINANCE & CAO	Jan 08 '24	Sale	28.64	1,188	34,025	37,499	Jan 10 04:11 PM
Golden Lee Scott	CHIEF MEDICAL OFFICER	Jan 08 '24	Sale	28.64	775	22,196	39,139	Jan 10 04:06 PM
Almstead Neil Gregory	CHIEF TECHNICAL OPS OFFICER	Jan 08 '24	Sale	28.64	53	1,518	3,834	Jan 10 04:03 PM
Klein Matthew B.	CHIEF EXECUTIVE OFFICER	Jan 05 '24	Sale	27.15	10,107	274,393	168,155	Jan 09 04:29 PM
Gravier Pierre	CHIEF FINANCIAL OFFICER	Dec 12 '23	Buy	25.81	7,700	198,736	33,700	Dec 14 04:38 PM
Young Alethia	Director	Sep 06 '23	Option Exercise	27.85	11,666	324,898	16,067	Sep 08 04:02 PM
Young Alethia	Director	Sep 06 '23	Sale	39.86	11,666	464,972	9,067	Sep 08 04:02 PM
SCHMERTZLER MICHAEL	Director	Jun 07 '23	Sale	44.86	1,000	44,860	116,766	Jun 09 04:03 PM
Reeve Emma	Director	May 23 '23	Option Exercise	33.38	2,652	88,520	8,602	May 24 04:12 PM
Reeve Emma	Director	May 23 '23	Sale	59.53	2,652	157,885	7,200	May 24 04:12 PM
Reeve Emma	Director	May 22 '23	Option Exercise	33.37	7,116	237,484	11,148	May 24 04:12 PM
Reeve Emma	Director	May 22 '23	Sale	59.53	7,116	423,630	7,200	May 24 04:12 PM
Pauwels Eric	CHIEF BUSINESS OFFICER	May 22 '23	Sale	59.01	2,013	118,791	47,553	May 23 04:05 PM
Pauwels Eric	CHIEF BUSINESS OFFICER	May 19 '23	Sale	58.96	6,403	377,491	49,566	May 23 04:05 PM
Pauwels Eric	CHIEF BUSINESS OFFICER	May 18 '23	Sale	58.71	788	46,267	55,969	May 19 04:04 PM
Pauwels Eric	CHIEF BUSINESS OFFICER	May 17 '23	Sale	58.50	8,048	470,822	56,757	May 19 04:04 PM
Jacobson Allan Steven	Director	May 11 '23	Option Exercise	10.85	23,000	249,550	35,348	May 12 04:08 PM
Jacobson Allan Steven	Director	May 11 '23	Sale	55.08	23,000	1,266,930	12,348	May 12 04:08 PM
Utter Christine Marie	SVP, FINANCE & CAO	Apr 21 '23	Option Exercise	33.02	4,692	154,930	42,380	Apr 25 04:09 PM
Utter Christine Marie	SVP, FINANCE & CAO	Apr 21 '23	Sale	55.06	4,692	258,326	38,059	Apr 25 04:09 PM
Reeve Emma	Director	Apr 21 '23	Sale	55.05	4,328	238,258	7,200	Apr 25 04:08 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PTCT

PTC Therapeutics Inc

Upgrade your FINVIZ experience